Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x100px

Product › Details

cancer immunotherapy (immuno-oncology, I-O)

	Next higher product group	cancer drug
	Status	2012-10-06

Record changed: 2025-03-19

Picture Swiss Biotech Association Global Village 2025 SBD25 Basel 650x200px

More documents for cancer immunotherapy (immuno-oncology, I-O)

[1] Nouscom S.r.l.. (12/3/24). "Press Release: Nouscom Appoints Seasoned Executive Eckhard Niemeier as Chief Business Officer". Basel....
[2] Medigene AG. (11/26/24). "Press Release: Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment". Basel....
[3] Immatics N.V.. (10/10/24). "Press Release: Immatics Announces Proposed $150 Million Public Offering". Houston, TX & Tübingen....
[4] ImmunOs Therapeutics AG. (9/17/24). "Press Release: ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base"....
[5] Immatics N.V.. (7/31/24). "Press Release: Immatics Appoints Alise Reicin to Board of Directors". Houston, TX & Tübingen....
[6] Boehringer Ingelheim. (7/29/24). "Press Release: Boehringer Ingelheim Secures Novel Immune Checkpoint Inhibitor with Acquisition of Nerio Therapeutics". Ingelheim & La Jolla, CA....
[7] Nouscom AG. (7/17/24). "Press Release: Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice President, Technical and CMC Development". Basel....
[8] Apeiron Biologics AG. (7/8/24). "Press Release: Apeiron Biologics to Be Acquired by Ligand Pharmaceuticals for USD 100 Million". Vienna....
[9] Bright Peak Therapeutics AG. (6/11/24). "Press Release: Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-IL18 Immunoconjugate Program Into Clinical Trials". Basel & San Diego, CA....
[10] Boehringer Ingelheim. (5/22/24). "Press Release: Boehringer Ingelheim and OSE Immunotherapeutics Expand Collaboration to Develop First-in-class Treatments for Cancer and Cardio-renal-metabolic Diseases". Ingelheim & Nantes....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)